FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Ashish Sharma, MBBS, MS, gives an update on aflibercept biosimilars around the world.
According to Sharma, there are five FDA-approved aflibercept biosimilars, with a molecule from Amgen available for use in the U.S., and real-world data are available from Iran.
Biosimilars for aflibercept 2 mg make sense because aflibercept is used globally by a majority of clinicians, and they will provide “a lot of help to our patients,” he said.
“Ultimately, our patients are the ones who will